LPL Financial
FOLD

LPL Financial’s Amicus Therapeutics FOLD Stock Holding History

LPL Financial’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-10,000
Closed -$142K – 6045
2025
Q4 		$142K Buy
+10,000
New +$98.2K ﹤0.01% 5537

Other funds holding FOLD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

LPL Financial's FOLD Position: Q1 2026 in Review

LPL Financial reduced its Amicus Therapeutics (FOLD) stake by 50% in Q1 2026, selling an estimated $256K and leaving 17,967 shares worth $260K. The position accounts for ﹤0.01% of the portfolio, ranked #5298.

LPL Financial first reported a position in FOLD in Q3 2015 and has held it in 31 quarters since. The position peaked at $510K in Q4 2025. 298 funds tracked by Wall St. Rank hold FOLD as of Q1 2026.

  • LPL Financial held 17,967 shares of Amicus Therapeutics worth $260K as of Q1 2026.
  • LPL Financial sold 17,838 Amicus Therapeutics shares in Q1 2026, an estimated $256K.
  • Amicus Therapeutics made up ﹤0.01% of LPL Financial's portfolio in Q1 2026, its #5298 holding.
  • LPL Financial first reported a position in Amicus Therapeutics in Q3 2015 and has held it in 31 quarters since.
  • LPL Financial's Amicus Therapeutics position peaked at $510K in Q4 2025.
  • 298 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q1 2026.

Based on LPL Financial's 13F filing for Q1 2026, filed 6 May 2026.